Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
JAMA|February 10, 2011
Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infantsChristine E Jones, Shalena Naidoo, Corena De Beer, et al.Neonatology|February 8, 2014
Purified human breast milk MUC1 and MUC4 inhibit human immunodeficiency virusYolanda Mthembu, Zoe Lotz, Marilyn Tyler, et al.Neonatology|September 20, 2007
Inhibition of human immunodeficiency virus type 1 activity by purified human breast milk mucin (MUC1) in an inhibition assayHabtom H Habte, Corena de Beer, Zoë E Lotz, et al.Journal of Medical Microbiology|March 7, 2018
Human respiratory syncytial virus: prevalence, viral co-infections and risk factors for lower respiratory tract infections in children under 5 years of age at a general hospital in the Democratic Republic of CongoLandry Kabego, Serge Balol'Ebwami, Joe Bwija Kasengi, et al.Journal of Medical Virology|June 24, 2010
Young age a predictor of weak reactivity in a rapid antibody test in infants infected with HIVLeana Maree, Gert U van Zyl, Shelley L Lotter, et al.Plos Computational Biology|December 21, 2023
Insights to HIV-1 coreceptor usage by estimating HLA adaptation with Bayesian generalized linear mixed modelsAnna Hake, Anja Germann, Corena de Beer, et al.Virology Journal|May 21, 2008
The inhibition of the Human Immunodeficiency Virus type 1 activity by crude and purified human pregnancy plug mucus and mucins in an inhibition assayHabtom H Habte, Corena de Beer, Zoë E Lotz, et al.Journal of Tropical Pediatrics|May 5, 2012
HIV-exposed uninfected infants are at increased risk for severe infections in the first year of lifeAmy Slogrove, Brian Reikie, Shalena Naidoo, et al.Vaccine|April 8, 2016
Delayed BCG immunization does not alter antibody responses to EPI vaccines in HIV-exposed and -unexposed South African infantsAnneke C Hesseling, Anna K Blakney, Christine E Jones, et al.Annals of the New York Academy of Sciences|January 3, 2006
Anti-HIV, anti-poxvirus, and anti-SARS activity of a nontoxic, acidic plant extract from the Trifollium species Secomet-V/anti-vac suggests that it contains a novel broad-spectrum antiviralGirish J Kotwal, Jennifer N Kaczmarek, Steven Leivers, et al.Pageof 3